4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-049119
Chief Medical Officer sold 17,500 shares at $18.04 ($315,700)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2018-08-29 | Sale | −17,500 | $18.04 | $315,700 | 218,390 | I: show line 1 in the form |
| Open-market sales · 17,500 sh · avg $18.04 · $315,700 | |||||||
Loading xslF345X03/doc4.xml…